| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc / Ma (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.48M | - | |
| COO | 63.4K | $28.71M | - | |
| VP | 51.1K | $23.14M | - | |
| VP | 42.3K | $19.16M | - | |
| Other | 24.0K | $10.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 360 | $421.77 | $151,837.20 | -0.6% | +5.3% | +14.5% | |
| Feb 21, 2024 | Sachdev Amit | EVP Chief Patient &Ext Af Off | Sell | 3,191 | $421.77 | $1,345,868.07 | -5.0% | +5.3% | +14.5% | |
| Feb 21, 2024 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 1,201 | $421.77 | $506,545.77 | -6.1% | +5.3% | +14.5% | |
| Feb 21, 2024 | Arbuckle Stuart A | EVP, COO | Sell | 3,603 | $421.77 | $1,519,637.31 | -5.7% | +5.3% | +14.5% | |
| Feb 21, 2024 | Altshuler David48 | EVP, Global Research And CSO | Sell | 3,002 | $421.77 | $1,266,153.54 | -8.1% | +5.3% | +14.5% | |
| Feb 20, 2024 | Atkinson Edward Morrow III49 | EVP, Chief Technical Ops. Off. | Sell | 801 | $420.79 | $337,052.79 | -3.9% | +6.0% | +12.2% | |
| Feb 20, 2024 | Tatsis Ourania48 | EVP, Chief Reg. &Quality Off. | Sell | 480 | $420.79 | $201,979.20 | -0.8% | +6.0% | +12.2% | |
| Feb 20, 2024 | Sachdev Amit | EVP Chief Patient &Ext Af Off | Sell | 4,254 | $420.79 | $1,790,040.66 | -6.2% | +6.0% | +12.2% | |
| Feb 20, 2024 | Altshuler David48 | EVP, Global Research And CSO | Sell | 4,002 | $420.79 | $1,684,001.58 | -9.8% | +6.0% | +12.2% | |
| Feb 20, 2024 | Arbuckle Stuart A | EVP, COO | Sell | 4,804 | $420.79 | $2,021,475.16 | -7.1% | +6.0% | +12.2% |